Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 5;10(3):405.
doi: 10.3390/biom10030405.

PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease

Giorgio Giaccone  1 , Fabio Moda  1
Affiliations
Review

PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease

Giorgio Giaccone et al. Biomolecules. .

Abstract

Prion diseases are neurodegenerative and invariably fatal conditions that affect humans and animals. In particular, Creutzfeldt-Jakob disease (CJD) and bovine spongiform encephalopathy (BSE) are paradigmatic forms of human and animal prion diseases, respectively. Human exposure to BSE through contaminated food caused the appearance of the new variant form of CJD (vCJD). These diseases are caused by an abnormal prion protein named PrPSc (or prion), which accumulates in the brain and leads to the onset of the disease. Their definite diagnosis can be formulated only at post-mortem after biochemical and neuropathological identification of PrPSc. Thanks to the advent of an innovative technique named protein misfolding cyclic amplification (PMCA), traces of PrPSc, undetectable with the standard diagnostic techniques, were found in peripheral tissues of patients with vCJD, even at preclinical stages. The technology is currently being used in specialized laboratories and can be exploited for helping physicians in formulating an early and definite diagnosis of vCJD using peripheral tissues. However, this assay is currently unable to detect prions associated with the sporadic CJD (sCJD) forms, which are more frequent than vCJD. This review will focus on the most recent advances and applications of PMCA in the field of vCJD and other human prion disease diagnosis.

Keywords: Creutzfeldt-Jakob disease; PMCA; disease biomarker; neurodegeneration; prion.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest

References

    1. Knight R., Brazier M., Collins S.J. Prions. KARGER; Basel, Switzerland: 2004. Human Prion Diseases: Cause, Clinical and Diagnostic Aspects; pp. 72–97. - PubMed
    1. Gambetti P., Kong Q., Zou W., Parchi P., Chen S.G. Sporadic and familial CJD: Classification and characterisation. Br. Med. Bull. 2003;66:213–239. doi: 10.1093/bmb/66.1.213. - DOI - PubMed
    1. Ladogana A., Puopolo M., Croes E.A., Budka H., Jarius C., Collins S., Klug G.M., Sutcliffe T., Giulivi A., Alperovitch A., et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005;64:1586–1591. doi: 10.1212/01.WNL.0000160117.56690.B2. - DOI - PubMed
    1. Mead S. Balancing Selection at the Prion Protein Gene Consistent with Prehistoric Kurulike Epidemics. Science (80-. ) 2003;300:640–643. doi: 10.1126/science.1083320. - DOI - PubMed
    1. Collinge J. Prion Diseases of Humans and Animals: Their Causes and Molecular Basis. Annu. Rev. Neurosci. 2001;24:519–550. doi: 10.1146/annurev.neuro.24.1.519. - DOI - PubMed

MeSH terms